Hybrid study designs can be advantageous for the generation of real world evidence, providing a potential solution to the challenges presented by observational studies.
The Coalition for Epidemic Preparedness Innovations announced a collaboration with IDT Biologika for MERS vaccine development in which IDT will receive up to $36m.
Randomized controlled trials are the fastest way to identify vaccines in an outbreak, but more collaboration is needed among international researchers – including CROs.
The renewed contract covers a range of research related services, including monitoring therapeutic trials, prevention trials, and vaccines work, with the ultimate goal of an "AIDS-free generation."
Zika researchers are using animal models and epidemiological studies to try and determine if the virus causes birth defects and neurological disorders.
A professor who conducted fast-track trials during last year’s Ebola outbreak says next time such trials must be part of humanitarian response… because there will be a next time.
Thermo Fisher Scientific has developed new software via a partnership with the Special Bacteriology Reference Laboratory at the CDC (Centers for Disease Control and Prevention) that helps public health labs to more quickly identify microbial pathogens...
The NFL (National Football League) may be getting more serious about its players’ health as it recently signed a five-year agreement with Quintiles to continue and expand upon its Injury Surveillance and Analytics (ISA) service to track player injuries...
Access to portable and flexible technology could be one way of containing transmissible diseases says G-CON as it launches a more readily deployable version of its ‘POD’ manufacturing suite.
Evotec has partnered with Shire to develop inhibitors against Fabry’s disease and says such collaborations will grow as Big Pharma increasingly looks towards rare diseases.
In order to ensure uniformity on the state and federal levels, India’s CDSCO (Central Drugs Standard Control Organization) has released seven procedural criteria for state drug inspectors to abide by.
California-based CRO Agility Clinical and EU-based PSR Orphan Experts have partnered to allow orphan drug companies to utilize their safety and regulatory knowledge in both markets.
Medecins Sans Frontieres (MSF) wants Brazil to streamline its validation process for the API benznidazole after global stocks of the Chagas disease treatment drop to critical levels.
Contract research organisation (CRO) Quintiles has been named as a preferred provider by a global consortium focused on the development of drugs for neglected diseases.
Hunt Biosciences is collaborating with Tissue Solutions to promote general population blood samples gathered over the past 25 years for acceleration of biomarker discovery and validation.
Almac has entered into a partnership with FACIT.org to gain PRO and QoL assessments which it believes will help it recruit patients and generate high quality data for regulatory submissions.
As the clinical trial activities continue to flock towards emerging
countries such as India, Morocco wants its share has been making
efforts to make itself attractive to international trial sponsors.
New research has suggested only seven per cent of drug applications
for treating people with rare diseases were approved in Europe
between 2000 and 2004, despite the fact that there are currently
more than 5,000 conditions needing...
In the UK, The Health Protection Agency is planning to revamp the
Food, Dairy, Water and Environmental (FDWE) laboratory service
network from this November to deal with new outbreaks and
emergencies.
